pembrolizumab
merck
['pembro']
the fda approval of pembrolizumab for adult and pediatric patients with tumor mutational burden (tmb) 10: a decision centered on empowering patients and their physicians 
Oncologist | Associate Prof | Executive Director-Research, MD Anderson Cancer Network | Medical Director, Clinical Center for Targeted Therapy. Tweets = my own.